FDA OKs brain hemorrhage solution from Arbor Pharmaceuticals

05/15/2013 | American City Business Journals

Arbor Pharmaceuticals has received federal approval for its Nymalize oral solution to address brain hemorrhage. "Having an oral version of this product may help reduce the medication errors we've seen from erroneous intravenous administration of the contents of oral capsules," said FDA official Russell Katz.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care